Persistent Hypoglycemia Induced by Long-acting Insulin Degludec
- PMID: 34483209
- PMCID: PMC8987256
- DOI: 10.2169/internalmedicine.7915-21
Persistent Hypoglycemia Induced by Long-acting Insulin Degludec
Abstract
A 58-year-old Japanese man was brought to the emergency room due to disturbance of consciousness. He regained consciousness on the day of admission and started taking hospital meals, but he needed intravenous glucose administration for eight days. The total amount of glucose administration was 4,464 g. It took over three weeks for exogenous insulin to be almost undetectable. While degludec binds to albumin and exerts glucose-lowering effects for a long time, the above-mentioned period of three weeks was consistent with the half-life of albumin. Hypoglycemia induced by massive dose of insulin degludec is persistent and prominent.
Keywords: a pitfall; diabetes care; insulin degludec; insulin therapy; severe hypoglycemia.
Conflict of interest statement
References
-
- Frier BM. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications. Nat Rev Endocrinol 10: 711-722, 2014. - PubMed
-
- Shah P, Rahman SA, Demirbilek H, Güemes M, Hussain K. Hyperinsuliaemic hypoglycaemic in children and adults. Lancet Diabetes Endocrinol 5: 729-742, 2017. - PubMed
-
- International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol 7: 385-396, 2019. - PubMed
-
- Ghosal S, Sinha B. Hypoglycaemia and CV risk: perceptions and reality. Diabetes Metab Syndr 9: 364-365, 2015. - PubMed
